Suppliers / Symbio Pharmaceuticals

Symbio Pharmaceuticals

United States 39 employees Updated 9 July 2026

Symbio Pharmaceuticals is an API manufacturer based in United States. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with CDSCO (India) and EMA.

2
active US DMFs
0
valid CEPs
0
registered plants
4
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Minoxidil US FDA 1
Ursodeoxycholic Acid US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 3 None
EMA 1 None

Comparing suppliers?

Choose your molecules and target markets. Symbio Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability